Understanding GLP-1 and GLP-1 Receptor Agonists GLP-1, or glucagon-like peptide-1, is a hormone produced in the intestines in response to food intake
Abstract Tirzepatide is the first dual long-acting glucose-dependent insulinotropic polypeptide receptor and glucagon-like peptide-1 receptor agonist indicated for the treatment of type 2 diabetes in adults, for reducing excess body weight and maintaining long-term weight reduction in adults with obesity or overweight and at least one weight-related comorbid condition, and for treating obstructive sleep apnea in adults with obesity
Longer-acting formulations with monthly dosing aim to reduce treatment burden and improve adherence
Common causes include liver disease (which releases stored B12), kidney disease (reducing B12 clearance), haematological malignancies, solid tumours, and excessive supplementation
If you are pregnant, breastfeeding, have a medical condition, or use prescription skin treatments, ask a clinician before use
Key Benefits: A beauty-focused IV infusion designed to support skin health, antioxidant balance, and hydration
